Al-SereitiMREdekiTLledoPTurnerP. The effects of timolol on intraocular pressure and exercise heart rate in poor and extensive debrisoquine metabolisers. Int J Clin Pharmacol Res1990;10:339–45.
2.
NadelmannJFrishmanWH. Clinical use of beta-adrenoceptor blockade in systemic hypertension. Drugs1990;39:862–76.
3.
QuyyumiAAWrightCMockusLFoxKM. Effect of partial agonist activity in beta-blockers in severe angina pectoris: A double-blind comparison of pindolol and atenolol. BMJ1984;289:951–3.
4.
WaidenRJTomlinsonBGrahamBLiuJBPrichardBNC. Withdrawal phenomena after atenolol and bopindolol: Haemodynamic responses in health volunteers. Br J Clin Pharmacol1990;30:557–65.
5.
WilhelmsenL. Practical guidelines for drug therapy after myocardial infarction. Drugs1989;38:1000–7.
6.
CruickshankJMPrichardBNC. Beta-blockers in clinical practice. Edinburgh: Churchill Livingstone, 1987:577–636.
7.
Vaughan WilliamsEM. Significance of classifying antiarrhythmic actions since the Cardiac Arrhythmia Suppression Trial. J Clin Pharmacol1991;31:123–35.
8.
PoynardTCalesPPastaL. Beta adrenergic antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. N Engl J Med1991;324:1532–8.
9.
TurnerP. Therapeutic uses of beta-adrenoceptor blocking drugs in the central nervous system in man. Postgrad Med J1989;65:1–6.
10.
AnderssonKEVingeE. Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine. Drugs1990;39:355–73.
11.
FeelyJPedenN. Use of beta-adrenoceptor blocking drugs in hyperthyroidism. Drugs1984;27:425–46.
12.
NovackGD. Ophthalmic beta-blockers since timolol. Surv Ophthalmol1987;31:307–27.
13.
TurnerP. Recent observations on drugs and human fertility. Postgrad Med J1988;64:578–80.
14.
CruickshankJMPrichardBNC. Beta-blockers in clinical practice. Edinburgh: Churchill Livingstone, 1987: 781–923.
15.
ConnacherAALakieMPowersNEltonRAWalshEGJungRT. Tremor and the anti-obesity drug BRL26830A. Br J Clin Pharmacol1990;30: 613–15.
